✦ LIBER ✦

The current role of neoadjuvant chemotherapy in the management of cervical carcinoma

✍ Scribed by Antonio González-Martín; Lucía González-Cortijo; Natalia Carballo; Juan F. Garcia; Fernando Lapuente; Alejandro Rojo; Luis M. Chiva

Book ID: 113961636
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 138 KB
Volume: 110
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of neoadjuvant chemotherapy in

The role of neoadjuvant chemotherapy in advanced ovarian carcinoma

✍ Vergote, I.B.; De Wever, I.; Tjalma, W.; Van Gramberen, M.; Van Dam, P. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 155 KB

The role of radical hysterectomy and neo

The role of radical hysterectomy and neoadjuvant chemotherapy in carcinoma of the cervix

✍ David H. Moore 📂 Article 📅 2002 🏛 Current Science Inc. 🌐 English ⚖ 326 KB

P10 Neoadjuvant chemotherapy and radioth

P10 Neoadjuvant chemotherapy and radiotherapy in the treatment of the cervical carcinoma

✍ Frezza, P; Elmo, M; Guida, C; Silvestro, G; Maffeo, A; Orientale, A; Ferrari, E 📂 Article 📅 1996 🏛 Elsevier 🌐 French ⚖ 114 KB

Neoadjuvant, adjuvent and palliative che

Neoadjuvant, adjuvent and palliative chemotherapy (VBP) in the patients of cervical carcinoma

✍ S.J. Kim 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Role of chemotherapy in the management o

Role of chemotherapy in the management of vulvar carcinoma

✍ Federica Tomao; Chiara Di Tucci; Claudia Marchetti; Giorgia Perniola; Filippo Be 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 196 KB

The role of chemotherapy in the manageme

The role of chemotherapy in the management of nasopharyngeal carcinoma

✍ Anthony T. C. Chan; Peter M. L. Teo; Thomas W. T. Leung; Philip J. Johnson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Background: Nasopharyngeal carcinoma (npc) is a radiosensitive tumor for which there is a high local control rate after radical radiotherapy (rt). however, for patients with locoregionally advanced disease, the rate of distant metastasis is high and the 5-year overall survival rate is poor. ##